Posts Tagged ‘pharmaceutical’

« Older Entries |

Big drug companies might cut R&D, delay new drugs if pharmacare means more generics, Ottawa warned

Tuesday, April 16th, 2019

… brand-name pharmaceutical companies may respond to a broad shift to generic drugs by delaying the introduction of new drugs in the Canadian market or by reducing the R&D activities that they undertake in the country,” said the analysis, labelled “secret,” … The proposal calls for an expanded list of countries Canada can use when comparing patented drug prices… to take into consideration when assessing whether a drug is overpriced.

Tags: , , ,
Posted in Health Policy Context | No Comments »


How Billionaires and Big Pharma Battled Canada’s National Drug Plan

Monday, April 8th, 2019

Batt found powerful players — including insurance and drug companies — profit from the current system. And that they had unleashed a major, expensive lobbying, PR and public campaign to fight a national pharmacare program… It’s time Canadians enjoyed a common sense pharmacare plan built to provide coverage for everyone, control costs and keep prices down. It’s time to do what’s right for the public’s health and the country’s economy.

Tags: , , , , , , , , , ,
Posted in Governance Debates | No Comments »


NDP pharmacare plan sets a new standard

Monday, April 8th, 2019

… families now enjoying private drug insurance would save $550 a year on average under a universal public scheme. Employers that offer drug coverage to their workers would pay on average $600 less per employee. In short, Canadians would pay more in taxes for pharmaceuticals but less overall. The NDP is sketchy on the politics of its plan, particularly on how to get the provinces to agree.

Tags: , , , , , , ,
Posted in Health Debates | No Comments »


Maytree’s roundup of the federal government’s 2019 budget

Thursday, March 28th, 2019

The highlights of the budget included support for first-time home buyers, retraining during working-age, retirement security, and funding for a national drugs agency to start initial work on important parts of a (potential) pharmacare program… also a significant investment in Indigenous communities and reconciliation.

Tags: , , , , , ,
Posted in Governance Policy Context | No Comments »


On Pharmacare, the Liberals offer big questions and small investments

Wednesday, March 20th, 2019

… If [the federal government] were to directly fund and manage drug coverage, there would be less integration in the management of overall health care costs and provinces would have less incentive for cost-effective choices between drugs and other inputs to health care… One hopes that the final report on the Implementation of National Pharmacare will… clarify the intended scope of public drug coverage and Ottawa’s intended role in a new national pharmacare system.

Tags: , , , ,
Posted in Health Delivery System | No Comments »


Federal Budget Response 2019

Wednesday, March 20th, 2019

On pharmacare: “Today’s measures don’t fulfill the bold promises of national pharmacare including hundreds of dollars of savings per family in both insurance and out-of-pocket drug costs. / On decent work and skills training:… workers are now being asked to pay for their own training. / On housing: “… Taking out new loans from CMHC or retirement savings doesn’t make housing more affordable–it just allows for another source of debt financing that must be repaid. / What’s missing: Funding for a national child care plan

Tags: , , , , , ,
Posted in Governance Debates | No Comments »


After Bill Morneau’s budget, Liberals should move on pharmacare

Wednesday, March 20th, 2019

The absence of comprehensive prescription drug coverage is the most glaring hole in our much-vaunted medicare system… Setting up a true national pharmacare program will be expensive and difficult, involving major push-back from the insurance industry and complex negotiations with the provinces. But the Liberals should not shy away from the challenge… they came into office promising to make real changes in the lives of ordinary people

Tags: , , , , , ,
Posted in Health Policy Context | No Comments »


Assessing The National Pharmacare Report

Tuesday, March 19th, 2019

The lack of clarity in the scope of a national formulary and associated listing requirements for public insurance also leaves the future role for private insurance companies largely undefined. If the formulary is comprehensive and the listing agreements binding, then there may be only a minor role for private drug insurance. If, however, the formulary covers only essential medicines and provinces retain autonomy in listing decisions, the role of private insurance would remain largely unchanged.

Tags: , , , , , ,
Posted in Health Policy Context | No Comments »


In the real world, encouraging signs for pharmacare

Monday, March 11th, 2019

… universal pharmacare, while it would cost Canadians less in total, would cost Canadian governments more – which is why finance ministers such as Bill Morneau are wary of it… a federal-provincial-territorial-Indigenous agency could co-exist with a fill-in-the-gaps system. But it makes more sense to go to all of this bother only for something more comprehensive, such as universal pharmacare.

Tags: , , , , , , , , ,
Posted in Health Debates | No Comments »


The Trudeau government’s weak start on pharmacare

Saturday, March 9th, 2019

… its report contains no plan for pharmacare at all. It talks only about creating “building blocks” that could someday, maybe, contribute to a plan… It warns that “without reform, the system will soon be at the breaking point.” But neither the Trudeau government nor its advisory council has yet been willing to follow through to the obvious answer: universal national pharmacare.

Tags: , , , , , , , ,
Posted in Health Policy Context | No Comments »


« Older Entries |